Signaling through the Prostaglandin I2 Receptor IP Protects against Respiratory Syncytial Virus-Induced Illness
AUTOR(ES)
Hashimoto, Koichi
FONTE
American Society for Microbiology
RESUMO
The role of prostanoids in modulating respiratory syncytial virus (RSV) infection is unknown. We found that RSV infection in mice increases production of prostaglandin I2 (PGI2). Mice that overexpress PGI2 synthase selectively in bronchial epithelium are protected against RSV-induced weight loss and have decreased peak viral replication and gamma interferon levels in the lung compared to nontransgenic littermates. In contrast, mice deficient in the PGI2 receptor IP have exacerbated RSV-induced weight loss with delayed viral clearance and increased levels of gamma interferon in the lung compared to wild-type mice. These results suggest that signaling through IP has antiviral effects while protecting against RSV-induced illness and that PGI2 is a potential therapeutic target in the treatment of RSV.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=516432Documentos Relacionados
- Calpain Inhibition Protects against Virus-Induced Apoptotic Myocardial Injury
- Cigarette Smoke Alters Respiratory Syncytial Virus–Induced Apoptosis and Replication
- Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP
- Enhancement of respiratory syncytial virus-induced cytopathology by trypsin, thrombin, and plasmin.
- RhoA Interacts with the Fusion Glycoprotein of Respiratory Syncytial Virus and Facilitates Virus-Induced Syncytium Formation
